Wednesday, April 8, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026
    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026
    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Perspectives

Even after Lockdowns Eased, Pandemic Depression Persisted Across Social Classes

The Conversation by The Conversation
April 3, 2024
in Perspectives
0
Even after Lockdowns Eased, Pandemic Depression Persisted Across Social Classes

Even after lockdowns eased, pandemic depression persisted across social classes – new study

window view
The high and persistent prevalence of depression suggests that mental illness increased for all social classes during the COVID-19 pandemic.
piola666/E+ via Getty Images

Catherine Ettman, Boston University and Sandro Galea, Boston University

The Research Brief is a short take about interesting academic work.

The big idea

One year into the COVID-19 pandemic, we found that more than 1 in 5 U.S. adults reported probable depression in both spring 2020 and spring 2021. We also found that financial assets helped reduce the persistence of symptoms – but only to a point. Our recently published research highlights COVID-19’s continuing mental health effects on the U.S. population.

We launched a national study in March 2020 measuring mental health and assets. COVID-19 was a national emergency, as deaths were on the rise. Schools, workplaces and government offices closed as Americans were urged to stay home. At that time, we found that 27.8% of U.S. adults in our study reported symptoms of depression, such as losing interest in activities or feeling down or hopeless. This number was over three times as high as the national pre-pandemic depression estimate of 8.5%.

Woman wearing a surgical mask sits on the steps of an office building, resting her elbow on a bent knee holding her forehead, with her purse and work binder beside her.
A new study finds that depression increased for all social classes during the COVID-19 pandemic.
boy_anupong/Moment via Getty Images

Most striking to us was that a year into the pandemic, depression rates remained high, despite hopeful signs of reducing infections and deaths. In April 2021, people were lining up for COVID-19 vaccine shots, doctors were finding better COVID-19 treatments and efforts to reopen society were under way. But by that point, the share of adults in our survey reporting symptoms of depression had gone up to 32.8%.

Worse yet, that higher 2021 number included 20.3% who had reported symptoms of depression both in April 2020 and in April 2021. This finding suggests that poor mental health driven by the pandemic was both prevalent and persistent.

We also wanted to know which assets – financial, physical and social – might be influencing people’s mental health during the pandemic. In our first survey, we found that people who came into the pandemic with relatively few assets – especially financial ones – were more likely to be affected by COVID-19-related stresses.

In our April 2021 follow-up survey, we were interested in the relationship between mental health and asset status. We looked at financial assets such as personal savings, physical assets such as home ownership and social assets of education and marital status. We compared people who were similar in terms of marriage, education and home ownership. We found that people in households earning less than US$20,000 a year were 3.5 times as likely to report persistent depression symptoms as those making $75,000.

We also found that people who had $5,000 or more in savings or a bank account reported less persistent depression. Having more assets, however, did not reduce the depression-inducing stress of losing a job, suffering relationship problems or experiencing financial difficulties during the pandemic.

Why it matters

Nearly 1 million U.S. lives have been lost to COVID-19, and there have been almost 5 million hospitalizations. But measuring the effect of the pandemic on the nation’s mental health is just beginning. And we believe the pandemic’s sustained impact on the nation’s mental health is unprecedented.

What’s next

Our next move is to further examine areas of overlap between those who started the pandemic with fewer assets and those who suffered job losses, relationship problems or financial difficulties during the pandemic.

People who have fewer assets are the ones most at risk of depression, especially depression that lasts over time with social upheaval. Assets can be a cushion, but even they did not protect people from the harmful effects of stressors brought on by the pandemic. Our research shows that although the pandemic seems to be easing, Americans are still suffering. And they may continue to feel ill effects on their mental health for a long time to come.

[Get fascinating science, health and technology news. Sign up for The Conversation’s weekly science newsletter.]

Catherine Ettman, PhD Candidate, Boston University and Sandro Galea, Professor of Family Medicine, Boston University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

ShareTweet
The Conversation

The Conversation

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

Most employers are unknowingly steering their health plans toward higher costs and reduced control — until they understand how fiduciary missteps and anti-competitive contracts bleed their budgets dry. Katie Talento, a recognized health policy leader, reveals how shifting the network paradigm can save millions by emphasizing independent providers, direct contracting, and innovative tiering models.

Grounded in real-world case studies like Harris Rosen’s community-driven initiative, this episode dives deep into practical strategies to realign incentives—focusing on primary care, specialty care, and transparent vendor relationships. You'll discover how traditional carrier networks are often Trojan horses, locking employers into costly, opaque arrangements that undermine fiduciary duties. Katie breaks down simple yet powerful reforms: owning your data, eliminating conflicts of interest, and outlawing anti-competitive contract clauses.

We explore how a post-network framework—where patients are free to choose providers without restrictive network barriers—can massively reduce costs and improve health outcomes. You'll learn why independent, locally owned providers are vital to rebuilding trust, reducing unnecessary procedures, and reinvesting savings into the community. This conversation offers clarity on the unseen legal landmines employers face and actionable ways to craft health plans built on transparency, independence, and aligned incentives.

Perfect for HR pros, benefits advisors, physicians, and employer leaders committed to transforming healthcare from the ground up. If you’re tired of broken healthcare models draining your budget and frustrating your staff, this episode will empower you to take control by understanding and reshaping the very foundations of employer-sponsored health. Discover the blueprint for smarter, fairer, and more sustainable benefits.

Visit katytalento.com or allbetter.health to connect directly and explore how these innovations can work for your organization. Your path toward a healthier, more cost-effective future starts here.

Chapters

00:00 Introduction to Employer-Sponsored Health Plans
02:50 Understanding ERISA and Fiduciary Responsibilities
06:08 The Misalignment of Clinical and Financial Interests
08:54 Enforcement and Legal Implications for Employers
11:49 Redefining Networks: The Post-Network Framework
25:34 Navigating Healthcare Contracts and Cash Payments
27:31 Understanding Employer Health Plan Structures
28:04 The Role of Benefits Advisors in Health Plans
30:45 Governance and Data Ownership in Health Plans
37:05 Case Study: The Rosen Hotels' Health Model
41:33 Incentivizing Healthy Choices in Healthcare
47:22 Empowering Primary Care and Independent Providers
The Hidden Costs Employers Don’t See in Traditional Health Plans
YouTube Video xhks7YbmBoY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

by Daily Remedy
March 30, 2026
0

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • 7 Shocking Reasons Why You’re Your Best Advocate

    7 Shocking Reasons Why You’re Your Best Advocate

    0 shares
    Share 0 Tweet 0
  • Approval Without Certainty

    0 shares
    Share 0 Tweet 0
  • The Pollution and Alzheimers Connection

    3 shares
    Share 0 Tweet 0
  • The Incretin Arms Race

    0 shares
    Share 0 Tweet 0
  • An Evening’s Kiss

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy